Canada:
New Court Proceedings - February 2019
08 March 2019
Smart & Biggar
To print this article, all you need is to be registered or login on Mondaq.com.
For complete details about these proceedings,
click here.
PMNOC Actions
abiraterone acetate (ZYTIGA): Janssen and BTG v
Sandoz
abiraterone acetate (ZYTIGA): Janssen and BTG v
Pharmascience
fingolimod (GILENYA): Novartis v Natco
fampridine (FAMPYRA): Biogen and Acorda v
Pharmascience
Other Actions
naproxen/esomeprazole magnesium (VIMOVO): Mylan
v AstraZeneca
fingolimod (GILENYA): Novartis v Accord,
Apotex, Marcan, Mylan, Pharmascience, Taro and Teva
The preceding is intended as a timely update on Canadian
intellectual property and technology law. The content is
informational only and does not constitute legal or professional
advice. To obtain such advice, please communicate with our offices
directly.
POPULAR ARTICLES ON: Litigation, Mediation & Arbitration from Canada
Five Need-to-Know Decisions In Commercial Litigation
Blake, Cassels & Graydon LLP
Recent decisions from Canadian courts will impact businesses in various industries. Below are five takeaways from commercial cases across the country to help your business stay ahead of litigation risk...
Affidavit Evidence 101
Reynolds Mirth Richards & Farmer
When picturing legal proceedings, many people envision dramatic courtroom trials with witnesses taking the stand. However, in Alberta, civil trials (unlike criminal trials) are rare.